[HTML][HTML] Sensitivity and specificity of human papillomavirus (HPV) 16 early antigen serology for HPV-driven oropharyngeal cancer: a systematic literature review and …

J Hibbert, G Halec, D Baaken, T Waterboer, N Brenner - Cancers, 2021 - mdpi.com
Simple Summary Serum antibodies against human papillomavirus 16 (HPV16) proteins are
associated with HPV-driven oropharyngeal cancer (HPV-OPC). The HPV status of OPC …

Blood‐based biomarkers of human papillomavirus–associated cancers: A systematic review and meta‐analysis

S Balachandra, SB Kusin, R Lee, JM Blackwell… - Cancer, 2021 - Wiley Online Library
Background Despite the significant societal burden of human papillomavirus (HPV)–
associated cancers, clinical screening interventions for HPV‐associated noncervical …

Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients

KH Bhatt, MA Neller, S Srihari, P Crooks… - Journal of Experimental …, 2020 - rupress.org
Cellular immunotherapeutics targeting the human papillomavirus (HPV)–16 E6 and E7
proteins have achieved limited success in HPV-positive oropharyngeal cancer (OPC). Here …

[HTML][HTML] Immunodiagnosis and immunotherapeutics based on human papillomavirus for HPV-induced cancers

Z Dong, R Hu, Y Du, L Tan, L Li, J Du, L Bai… - Frontiers in …, 2021 - frontiersin.org
Infection with human papillomavirus (HPV) is one of the main causes of malignant
neoplasms, especially cervical, anogenital, and oropharyngeal cancers. Although we have …

Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update

K Devaraja, S Aggarwal, SS Verma, SC Gupta - Life Sciences, 2020 - Elsevier
Aims The current article provides a detailed account of the current understanding of
molecular and clinico-pathological aspects of Human papilloma virus (HPV) driven head …

Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach

G Di Credico, V Edefonti, J Polesel, F Pauli, N Torelli… - Oral oncology, 2019 - Elsevier
Objectives This study aimed at re-evaluating the strength and shape of the dose-response
relationship between the combined (or joint) effect of intensity and duration of cigarette …

[HTML][HTML] Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer

X Peng, I Woodhouse, G Hancock, R Parker, K Marx… - Iscience, 2023 - cell.com
Current immunotherapeutic approaches for human papillomavirus (HPV)-driven cervical
cancer target the viral oncogenes E6 and E7. We report viral canonical and alternative …

Solvent selective membrane routing and microfluidic architecture towards centrifugal automation of customisable bead based immunoassays

R Mishra, R Alam, D McAuley, T Bharaj… - Sensors and Actuators B …, 2022 - Elsevier
The success of bioanalytical technologies deployed at decentralised settings is governed by
various performance criteria such as user-friendliness, ease-of-use, cost per-test (at …

[HTML][HTML] Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Clinical Trial Demographics

TM Gordis, JL Cagle, SA Nguyen, JG Newman - Cancers, 2022 - mdpi.com
Simple Summary HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is
unique amongst oropharyngeal cancers in its high responsiveness to treatment and its lower …

Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer

C Fakhry, JR Qualliotine, Z Zhang, N Agrawal… - Cancer Prevention …, 2016 - AACR
Human papillomavirus (HPV) is responsible for increasing incidence of oropharyngeal
cancer. At present, there are no biomarkers in the surveillance algorithm for HPV-positive …